Ukr.Biochem.J. 2017; Volume 89, Issue 4, Jul-Aug, pp. 49-55

doi: https://doi.org/10.15407/ubj89.04.049

The experimental investigation of fibrinolytic system under the influence of flocalin in conditions of acute hypoxic kidney injury

A. I. Gozhenko1, Yu. I. Gubsky2, N. D. Filipets3,
О. О. Filipets3, O. A. Gozhenko1

1State Enterprise Ukrainian Research Institute for Medicine of Transport, Odessa;
2State Institution Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv;
3Higher State Educational Establishment of Ukraine Bukovinian State Medical University, Chernivtsi;
е-mail: filipec.natalja@bsmu.edu.ua

In the experiments on rats subjected to acute hypoxic histochemical nephropathy, caused by sodium nitrite and 2,4-dinitrophenol, fibrinolytic activities of blood plasma, urine, renal cortex, medulla, and papilla after treatment with flocalin – the activator of KATP channels, were studied­. It was shown that in the conditions of acute kidney hypoxic injury flocalin administration resulted in the increase and essential restoration of fibrinolysis in blood plasma diminished under hypoxia, which was due to the growth of non-enzymatic fibrinolysis, whereas in urine and renal medulla the appreciable increase of enzymatic fibrinolytic activity took place. Moreover, the treatment of hypoxic nephropathy animals by flocalin resulted in the marked restoration of kidney ion regulatory and protein excretory functions that proves the positive influence of KATP channels activation on the one of the biochemical mechanisms of acute kidney injury as well as the protective effect of flocalin in relation to tubular cells of nephron. The obtained results testify to the beneficial effects of KATP channels activation in the conditions of acute hypoxic kidneys injury.

Keywords: , ,


References:

  1. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature. 1983 Sep 8-14;305(5930):147-8. PubMed, CrossRef
  2. Moybenko OO, Strutynskyi RB, Yagupolskii LM, Mohort MA, Shalamai AS. Organization of industrial production of flokalin – new myotropic spasmolytic and cardioprotector. Sci Innov. 2009;5(1):80-84. (In Ukrainian). CrossRef
  3. Gozhenko A. I., Filipets N. D. Тhe renotropic effects of adenosine triphosphate-sensitive potassium channel activation depending on the functional state of kidneys in rats. Nephrology. 2013;17(2):87-90. (In Russian).
  4. Chernukha LM, Kashyrova OV, Lugovskoy EV, Komisarenko SV, Kolesnikova IN, Makohonenko YeM, Platonova TN, Pirogova LV, Gornickaya OV. Сlinical features of the state of hemostasis system at arteriovenous forms of congenital vascular malformations. Heart Vessels. 2015;2:65-73.
  5. Borys RM, Sirman VM, Nykytenko OP, Zukow W, Gozhenko AI. Description of dynamics change hemostasis, proteolysis, fibrinolysis and lipid peroxidation in kidney tissue. J Educ Health Sport. 2016;6(3):241-258.
  6. Lutz J, Menke J, Sollinger D, Schinzel H, Thürmel K. Haemostasis in chronic kidney disease. Nephrol Dial Transplant. 2014 Jan;29(1):29-40. PubMed, CrossRef
  7. Mahendran KB, Bhaskar MV, Santha K, Inmozhi R, Perumal KK. Plasma and Urinary Type IV Collagen Levels for Early Detection of Nephropathy in Type 2 Diabetes Mellitus Patients. Int J Health Sci (Qassim). 2016 Oct;10(4):492-498. PubMed, PubMedCentral
  8. Ribic C, Crowther M. Thrombosis and anticoagulation in the setting of renal or liver disease. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):188-195. PubMed, CrossRef
  9. Gozhenko AI, Kravchuk AV, Nikitenko OP, Moskolenko OM, Sirman VM. Functional Renal Reserve. Оdessa: Foenix; 2015. 180 p. (In Ukrainian).
  10. Pat. 90547 UA, IСP (2014.01) A61В 17/00. Method of Modeling Hypoxic Nephropathy / Filipets N. D., Davydenko I. S., Pashkovskyi V. M., Filipets О. О., Gozhenko A. I. Publ. 26.05.2014; Bul. N 10. (In Ukrainian).
  11. Strutynskyi RB, Moybenko OO, Chebanov VA, Gorobets NYu. Modeling of production industrial process of the drug flocalin and search of its optimally effective dose for treatment of heart diseases. Sci Innov. 2013;9(1):55–63. (In Ukrainian). CrossRef
  12. Berchin EB, Ivanov YuI. Methods of experimental study of kidneys and water-salt metabolism. Barnaul: The Altai Book Publishing house, 1972. 199 p. (Іn Russian).
  13. Mikheeva AI, Bogodarova IA. Sulphosalicylic method for determination of urine protein. Lab Delo. 1969;7:441-442. (Іn Russian).
  14. Mahalyas VM, Mikhyev AO, Rohovyy YuYe. Modern methods of experimental and clinical studies of the central research laboratory of Bukovyna State Medical Academy. Chernivtsi: BSMA, 2001. 42 p. (In Ukrainian).
  15. Akopova O, Nosar V, Gavenauskas B, Bratus L, Kolchinskaya L, Mankovska I, Sagach V. The effect of atp-dependent potassium uptake on mitochondrial functions under acute hypoxia. J Bioenerg Biomembr. 2016 Feb;48(1):67-75.  PubMed, CrossRef
  16. Baraldi O, Valentini C, Donati G, Comai G, Cuna V, Capelli I, Angelini ML, Moretti MI, Angeletti A, Piscaglia F, La Manna G. Hepatorenal syndrome: Update on diagnosis and treatment. World J Nephrol. 2015 Nov 6;4(5):511-20.  PubMed, PubMedCentral
  17. Lugovskoy E. V, Makogenenko E. M., Komysarenko S. V. Molecular mechanisms of fibrin formation and destruction. К.: Nauk. Dumka, 2013. 229 p. (In Ukrainian).
  18. Tkachuk VA, Plekhanova OS, Beloglazova IB, Parfenova EV. Role of multidomain structure of urokinase in regulation of growth and remodeling of vessels. Uкr Bіоkhim Zhurn. 2013;85(6):18-45. (Іn Ukrainian).  CrossRef
  19. Gozhenko АІ, Filipets ND. The influence of focalin on the biochemical markers of acute hypoxic histohemic nephropathy. 14th Reading of V.V. Podvysotskyi: sci.-pract. conference with international participation; 2015 May 27-28; Оdеssа, 2015. 55-56. (In Ukrainian).
  20. Yagupolskii LM, Petko KI, Tarasova YeV. Fluorine-containing potassium chanels activators – flokalin and it’s analogs. J Org Pharmac Chem. 2004; 2(4): 11-16. (In Ukrainian).
  21. Voitychuk O. I., Moybenko E. A., Shuba Y. M. ATP-dependent potassium channel opener flocalin regulates cardiac excitablity. Fiziol Zh. 2010;56(1):41-53. (In Ukrainian).
  22. Strutynska NA , Strutynskyi RB, Chorna SV, Semenykhina OM, Mys LA, Moibenko OO, Sagach VF. New fluorine-containing openersof ATP-sensitive potassium channels flokalin and tioflokalin inhibitcalcium-induced mitochondrial pore opening in rat hearts. Fiziol Zh. 2013;59(6):3-11. (In Ukrainian). PubMed
  23. Voitychuk OI, Srutynskyi RB, Shuba YM. Effects of ATP-dependent potassium channel activator flocalin include sodium and calcium channels inhibition in cardiomyocytes. Biophysical J. 2011;100(3):433a.  CrossRef
  24. Filipets ND, Gozhenko AI. Сomparative assessment of nephroprotective properties of potassium and calcium channel modulators in experimental renal injury. Exp Clin Pharmacol. 2014;77(1):10-12. (In Russian). PubMed
  25. Robles NR, Calvo C, Sobrino J, Espinel E, Esteban R, Mateos L, Macias JF. Lercanidipine valuable effect on urine protein losses: the RED LEVEL study. Curr Med Res Opin. 2016 Oct;32(sup2):29-34. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.